Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
2,412.00
+36.50 (1.54%)
Mar 27, 2026, 3:30 PM JST
5.98% (1Y)
| Market Cap | 536.78B +9.4% |
| Revenue (ttm) | 335.80B +13.6% |
| Net Income | 34.54B +16.8% |
| EPS | 148.61 +14.9% |
| Shares Out | 225.96M |
| PE Ratio | 15.99 |
| Forward PE | 16.12 |
| Dividend | 46.00 (1.93%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 1,078,700 |
| Average Volume | 945,455 |
| Open | 2,382.50 |
| Previous Close | 2,375.50 |
| Day's Range | 2,381.50 - 2,427.50 |
| 52-Week Range | 1,964.50 - 2,703.00 |
| Beta | -0.55 |
| RSI | 53.05 |
| Earnings Date | May 12, 2026 |